Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
4
×
boston blog main
boston top stories
san francisco blog main
startups
acute myeloid leukemia
adverum biotechnologies
ally bridge group
alnylam pharmaceuticals
ambit biosciences
athena countouriotis
beijing
big data analytics
biobucks
blackrock
boston
brett zbar
brii bio
brii biosciences
bristol-myers squibb
calistoga pharmaceuticals
car-t immunotherapy
casdin capital
checkpoint inhibitors
china
clinical trials
cormorant asset management
daiichi sankyo
deals
diabetic nephropathy
eventide asset management
focal segmental glomerulosclerosis
gilead sciences
glaxosmithkline
goldfinch bio
gsk
halozyme therapeutics
What
drug
4
×
million
4
×
new
biotech
cancer
medicines
pipeline
raised
therapeutics
year
adding
adds
alliance
analysis
areas
athena
bets
bio
biosciences
bio’s
boost
brii
bring
ceo
chief
company
countouriotis
develop
disease
diseases
earlier
employing
expensive
far
financing
genetic
gets
gilead
goldfinch
hepatitis
Language
unset
Current search:
million
×
" national top stories "
×
drug
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push